Additional Resources

Investors interested in learning more about Roche and Genentech can click on the following links to download more information.

ADR Information

Fact Sheet

Share Information

Reasons to Invest

120+
Years of combined expertise in biotech, pharma, and diagnostics
72
New molecule entities in the pipeline
31
Years in a row of increased dividends